Andreas MANTOULIDIS
Company: Boehringer Ingelheim
Job title: Research Lab Head
Seminars:
Targeting KRAS Mutations Beyond G12C: Advancing ACBI3 for Comprehensive KRAS Degradation and Tumour Regression 1:45 pm
day: Day 1, Track 2, PM
Remarks & End of Conference Day One 5:00 pm
day: Day 1, PM